KOSDAQ · Healthcare · ₩2T
₩23,800-4.42%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 9.3% · as of 26.10.26
Among 97 제약 peers
Quarterly Revenue Growth
“본업은 좋아졌지만 전체 성적은 더 살펴봐야 해요.”
In the company's words · 2026 2분기 filing